EUVIMEDEUVIMED entdecken
Crossref

Gene editing treatment strategies for retinitis pigmentosa assessed in Xenopus laevis carrying a mutant Rhodopsin allele

Farhad Ghaseminejad, Beatrice M. Tam, Colette N. Chiu, Joanna M. Feehan, Orson L. Moritz

Journal of Translational Genetics and Genomics · 2022 · 6 · 111-125

DOI: 10.20517/jtgg.2021.49 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Genetics and Genomics, 2022. Verfasst von Farhad Ghaseminejad und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Gefördert von: Canadian Institutes of Health Research, National Science and Engineering Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To examine the utility of gene editing therapies for retinitis pigmentosa using Xenopus laevis carrying a mutation in Rhodopsin.

Methods

Xenopus laevis were genetically modified using CRISPR-Cas9 based methods and characterized by Sanger sequencing, dot blot, electroretinography, and confocal microscopy.

Results

We identified genetically modified Xenopus laevis carrying a net 12 base pair deletion in the Rho.L gene. These animals have a retinal degeneration that is apparent by 14 days, with abnormal or missing rod outer segments, and a reduced electroretinogram signal. We prevented the majority of this retinal degeneration via a treatment strategy using a single sgRNA to neutralize the mutant allele via non-homologous end joining, yielding long-term improvements in histology and the electroretinogram. A second strategy using two sgRNAs to generate large deletions in the mutant allele was also successful, but did not significantly improve outcomes relative to the single-guide strategy as it was less efficient. We found limited evidence of success with a third strategy dependent on homology-directed repair; this treatment was also too inefficient to generate an outcome superior to the single-guide strategy.

Conclusion

Our results demonstrate the utility of this new Xenopus laevis model for rapidly assessing and comparing multiple gene-editing based treatment strategies. We conclude that it would be technically difficult to improve on the simple single-guide based strategy, as strategies requiring multiple successive events (such as cleavage followed by homology-directed repair) are likely to be less efficient.

Förderung

  • Canadian Institutes of Health Research
  • National Science and Engineering Research Council

Zitieren

APA

Ghaseminejad, F., Tam, B. M., Chiu, C. N., Feehan, J. M., & Moritz, O. L. (2022). Gene editing treatment strategies for retinitis pigmentosa assessed in Xenopus laevis carrying a mutant Rhodopsin allele. Journal of Translational Genetics and Genomics, 6, 111-125. https://doi.org/10.20517/jtgg.2021.49

Vancouver

Ghaseminejad F, Tam BM, Chiu CN, Feehan JM, Moritz OL. Gene editing treatment strategies for retinitis pigmentosa assessed in Xenopus laevis carrying a mutant Rhodopsin allele. Journal of Translational Genetics and Genomics. 2022;6:111-125. doi:10.20517/jtgg.2021.49

BibTeX
@article{Ghaseminejad2022,
  author = {Ghaseminejad, Farhad and Tam, Beatrice M. and Chiu, Colette N. and Feehan, Joanna M. and Moritz, Orson L.},
  title = {Gene editing treatment strategies for retinitis pigmentosa assessed in Xenopus laevis carrying a mutant Rhodopsin allele},
  journal = {Journal of Translational Genetics and Genomics},
  year = {2022},
  volume = {6},
  pages = {111--125},
  doi = {10.20517/jtgg.2021.49}
}
Kostenlos starten →